RENX:LSE Renalytix AI plc

GBX 35.00 0.00 0
Icon

Renalytix AI plc (RENX:LSE) Stock Analysis and Price Targets

COMMON STOCK | Health Information Services | LSE
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

GBX 35.00

0.00 (0.00)%

GBX 0.04B

0.03M

N/A

N/A

Icon

RENX:LSE

Renalytix AI plc (GBX)
COMMON STOCK | LSE
GBX 35.00
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

GBX 0.04B

N/A

GBX 35.00

Renalytix AI plc (RENX:LSE) Stock Forecast

N/A

Based on the Renalytix AI plc stock forecast from 0 analysts, the average analyst target price for Renalytix AI plc is not available over the next 12 months. Renalytix AI plc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Renalytix AI plc is Bearish, which is based on 1 positive signals and 6 negative signals. At the last closing, Renalytix AI plc’s stock price was GBX 35.00. Renalytix AI plc’s stock price has changed by +0.00% over the past week, +22.81% over the past month and -60.00% over the last year.

No recent analyst target price found for Renalytix AI plc
No recent average analyst rating found for Renalytix AI plc

Company Overview Renalytix AI plc

Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-...Read More

https://renalytix.com

1460 Broadway, New York, NY, United States, 10036

0

June

GBX

UK

Adjusted Closing Price for Renalytix AI plc (RENX:LSE)

Loading...

Unadjusted Closing Price for Renalytix AI plc (RENX:LSE)

Loading...

Share Trading Volume for Renalytix AI plc Shares

Loading...

Compare Performance of Renalytix AI plc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for RENX:LSE

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Renalytix AI plc (Sector: Health Information Services )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
CRW:LSE
Craneware Plc +40.00 (+1.82%) GBX0.76B 101.81 14.78

ETFs Containing RENX

Symbol Name RENX's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Renalytix AI plc (RENX:LSE) Stock

Stock Target Advisor's fundamental analysis for Renalytix AI plc's stock is Bearish.

Unfortunately we do not have enough data on RENX:LSE's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on RENX:LSE's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on RENX:LSE's stock to indicate if its overvalued.

The last closing price of RENX:LSE's stock was GBX 35.00.

The most recent market capitalization for RENX:LSE is GBX 0.04B.

Unfortunately we do not have enough analyst data on RENX:LSE's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Renalytix AI plc's stock.

As per our most recent records Renalytix AI plc has 0 Employees.

Renalytix AI plc's registered address is 1460 Broadway, New York, NY, United States, 10036. You can get more information about it from Renalytix AI plc's website at https://renalytix.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...